Aleksandra Rizo Crcareva
About Aleksandra Rizo Crcareva
Aleksandra Rizo Crcareva serves as the Chief Medical Officer at Geron Corporation, where she has worked since 2019. She holds an MD from the University Ss. Cyril and Methodius and has extensive experience in clinical oncology from previous roles at Johnson & Johnson and Celgene.
Current Role at Geron Corporation
Aleksandra Rizo Crcareva serves as the Chief Medical Officer at Geron Corporation, a position she has held since 2019. In this role, she is responsible for overseeing the medical strategy and clinical development of the company's oncology products. Geron Corporation is located in Menlo Park, California, and focuses on developing innovative therapies for cancer treatment.
Previous Experience in Clinical Oncology
Prior to her current role, Rizo Crcareva held several positions at Johnson & Johnson, where she worked for over a decade. She served as Senior Director, Clinical Leader for Clinical Oncology R&D from 2014 to 2017. Additionally, she was the Director of Clinical Oncology R&D from 2011 to 2014 and worked as an Associate Director in the same department from 2008 to 2011. Her experience at Johnson & Johnson provided her with extensive knowledge in clinical research and development in oncology.
Experience at Celgene
Aleksandra Rizo Crcareva worked at Celgene as Executive Director, Strategy and Clinical Lead for Clinical R&D from 2018 to 2019. During her time at Celgene, she contributed to the strategic direction and clinical development of oncology programs, further enhancing her expertise in the field.
Educational Background
Rizo Crcareva has a strong academic background in medicine and research. She studied at the University Ss. Cyril and Methodius, where she earned her Medical Doctor (MD) degree. Additionally, she completed her PhD studies at Rijksuniversiteit Groningen and The University of Tokyo, equipping her with a comprehensive understanding of medical science and research methodologies.